NCT06213974View on ClinicalTrials.gov

A Study of Maribavir in Adults and Children With Post-transplant Cytomegalovirus (CMV) Infection in Argentina

RecruitingOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

September 3, 2024

Primary Completion Date

June 1, 2026

Study Completion Date

September 1, 2026

Conditions
Cytomegalovirus (CMV)
Interventions
OTHER

No Intervention

This is non-interventional study.

Trial Locations (1)

C11119ACN

RECRUITING

IC Projects, City of Buenos Aires

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY